Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S ("Contera") are pleased
United Kingdom Kostenloser Wertpapierhandel Kenneth Vielsted Christensen Mike Wood Jin Li Prnewswire Vernalis Research
Source: finanznachrichten.de